Inventor
TUCCI FABIO C
US13 patents
⚠️ This page may combine multiple inventors who share the name “TUCCI FABIO C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROCRINE BIOSCIENCES INC
8 patentsUS7419983B2Sep 2, 2008
Gonadotropin-releasing hormone receptor antagonists and methods related thereto
NEUROCRINE BIOSCIENCES INC38 citations95
US7056927B2Jun 6, 2006
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC49 citations95
US7176211B2Feb 13, 2007
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC32 citations92
US6872728B2Mar 29, 2005
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC16 citations92
US6608197B2Aug 19, 2003
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC31 citations92
US6346534B1Feb 12, 2002
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC24 citations89
US7462625B2Dec 9, 2008
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC9 citations83
US7179815B2Feb 20, 2007
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
NEUROCRINE BIOSCIENCES INC11 citations83
EPIGEN BIOSCIENCES INC
4 patentsUS10570103B2Feb 25, 2020
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC3 citations70
US11427552B2Aug 30, 2022
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations59
US10526298B2Jan 7, 2020
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations49
US10000459B2Jun 19, 2018
Heterocyclic compounds useful in the treatment of disease
EPIGEN BIOSCIENCES INC0 citations49